Hepatoma Clinical Trials in Hangzhou, Zhejiang
2 recruitingHangzhou, Zhejiang, China
Showing 1–2 of 2 trials
Recruiting
Phase 1
MDN-001 Injection for the Treatment of Unresectable Primary Hepatocellular Carcinoma.
Unresectable Hepatocellular Carcinoma (HCC)Hepatoma
Suzhou Mednovo Yi Medical Technology Co., Ltd.40 enrolled8 locationsNCT07391839
Recruiting
Early Phase 1
The Treatment of Bioartificial Liver With hiHep Cells After Extensive Hepatectomy
Hepatoma Resectable
Sir Run Run Shaw Hospital10 enrolled1 locationNCT05035108